Master Alliance Provisions Guide (MAPGuide)

MPP (C-TAP) – Biotech Africa, COVID-19 Diagnostic, Patent & Material Sublicense Agreement

  • Liability | Insurance



10.4 Insurance. Immediately upon the first administration of a Product to a human in accordance with this Agreement, and for a period of ten (10) years after the expiration or earlier termination of this Agreement, the Sublicensee shall obtain and/or maintain, at its sole cost and expense, product liability insurance in amounts which are reasonable and customary in the pharmaceutical industry of the countries in which the Materials and Products are manufactured, distributed and sold (as relevant). Such product liability insurance shall insure against all liability, including product liability, personal liability, physical injury or property damage. The Sublicensee shall provide written proof of the existence of such insurance to MPP upon request.